Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients
Related Posts
Gunsalus RP, Humm E, Cook L, Wofford NQ, James KL, Pellegrini M, Morselli M, Ha SM, McInerney MJ. Whole genome sequence of the syntrophic benzoate-degrading[...]
Ahmad E, Ahmad S, Naeem A, Ahmed S, Shehzad M, Akram U, Ashraf H, Rehman OU, Ullah I, Ahmed R, Alraies C, Fonarow GC. Trends[...]
Asada H, Takami M, Mori S, Izawa Y, Kawamori H, Fukuzawa K. Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation. JACC[...]